ArticleJournal of enzyme inhibition and medicinal chemistry2022

2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights.

Mostafa M Elbadawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.